晚期慢性器官衰竭患者1年内接受生命维持治疗意愿的不稳定性
该多中心纵向研究纳入265例临床稳定的晚期COPD(GOLD III/IV期,n=105)、慢性心力衰竭(NYHA III/IV级,n=80)或慢性肾衰竭(需透析,n=80)荷兰门诊患者,在基线及4、8、12个月用Willingness to Accept Life-sustaining Treatment工具评估生命维持治疗意愿的稳定性。206例完成1年随访(平均年龄67.2岁,SD 13.1岁;64.1%男性)。总体接受生命维持治疗的比例随时间无变化,但个体轨迹显示约三分之二患者1年内至少改变一次意愿;接受高负担治疗的稳定性与CPR及机械通气意愿的稳定性之间未发现关联。作者结论提示预立医疗照护计划是患者与医生之间需定期重新评估的连续过程。
要点
- 265例晚期COPD、心衰或肾衰竭门诊患者中,206例完成1年随访,平均年龄67.2岁,64.1%男性。
- 总体接受生命维持治疗的比例1年内未随时间变化,但约三分之二患者个体意愿至少改变一次。
- 接受高负担治疗的稳定性与CPR及机械通气意愿的稳定性之间未发现关联。
- 作者认为预立医疗照护计划是患者与医生之间讨论具体情境偏好并需定期重新评估的连续过程。
适用人群与场景
- 荷兰多中心临床稳定的晚期慢性器官衰竭门诊患者:COPD GOLD III/IV期(n=105)、慢性心力衰竭NYHA III/IV级(n=80)、慢性肾衰竭需透析(n=80)。
- 基线及4、8、12个月随访评估;206例完成1年随访(平均年龄67.2岁,SD 13.1岁;64.1%男性)。
研究设计与关键结果
- 多中心纵向研究,纳入265例临床稳定的晚期COPD、慢性心力衰竭或慢性肾衰竭门诊患者,206例完成1年随访。
- 使用Willingness to Accept Life-sustaining Treatment工具在基线及4、8、12个月评估生命维持治疗意愿的稳定性。
- 1年内总体愿意接受生命维持治疗的患者比例未随时间变化。
- 个体轨迹显示约三分之二患者在1年内至少改变一次意愿。
- 接受高负担治疗的稳定性与CPR及机械通气意愿的稳定性之间未发现关联。
证据类型、等级与局限
- 证据类型:多中心纵向研究。
- 临床试验注册:荷兰国家试验注册库(NTR 1552)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为预立医疗照护计划是患者与医生之间的连续过程,应讨论具体情境的偏好并定期重新评估,以提供高质量终末期照护。
- 原文未据此给出具体药物、剂量或操作推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: For optimal end-of-life decision-making, it is important to understand the stability of patients' treatment preferences. The aim of this paper is to examine the stability of willingness to accept life-sustaining treatments during 1-year follow-up in Dutch patients with advanced chronic organ failure. In addition, we want to explore the association between willingness to accept high-burden treatment and preferences for CPR and mechanical ventilation (MV).
METHODS: In this multicenter longitudinal study, 265 clinically stable outpatients with advanced COPD (Global Initiative for Chronic Obstructive Lung Disease stage III/IV [n = 105]), chronic heart failure (New York Heart Association class III/IV [n = 80]), or chronic renal failure (requiring dialysis [n = 80) were visited at baseline and at 4, 8, and 12 months to assess the stability of life-sustaining treatment preferences using the Willingness to Accept Life-sustaining Treatment instrument.
RESULTS: Two hundred six patients completed 1-year follow-up (mean age, 67.2 years [SD, 13.1 years]; 64.1% men). Overall, proportions of patients who were willing to accept life-sustaining treatment during 1 year did not change over time. However, individual trajectories showed that about two-thirds of patients changed their preferences at least once during a year. Moreover, there was no association found between the stability of willingness to undergo high-burden therapy and the stability of preferences for CPR and MV.
CONCLUSIONS: The current findings show the complexity of preferences for end-of-life care and indicate once again that advance care planning is a continuous process between patients and physicians, in which preferences for specific situations are discussed and that needs to be regularly reevaluated to deliver high-quality end-of-life care.
CLINICAL TRIAL REGISTRATION: Netherlands National Trial Register (NTR 1552).
参考来源
- Houben CHM, Spruit MA, Schols JMGA, et al. Instability of Willingness to Accept Life-Sustaining Treatments in Patients With Advanced Chronic Organ Failure During 1 Year. Chest. 2016. PMID: 28007621. doi:10.1016/j.chest.2016.12.003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。